Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention: A Randomized Controlled Trial

Citation metadata

Publisher: American Medical Association
Document Type: Product/service evaluation
Length: 48 words

Document controls

Main content

Abstract :

The anticoagulant drug Integrilin may lower the risk of complications from stenting in patients with coronary artery disease, according to a study of 2,064 patients. Stents are small cylindrical devices that are placed inside coronary arteries to keep them open. However, this procedure can cause blood clot formation.

Source Citation

Source Citation   

Gale Document Number: GALE|A74700595